New Zealand markets open in 7 hours 16 minutes

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.3350+0.2650 (+6.51%)
As of 10:44AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close4.0700
Open4.0900
Bid4.3100 x 1100
Ask4.3600 x 1100
Day's range4.0900 - 4.3600
52-week range3.5300 - 11.3600
Volume1,195,250
Avg. volume7,326,375
Market cap606.696M
Beta (5Y monthly)1.60
PE ratio (TTM)N/A
EPS (TTM)-5.4100
Earnings date07 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est15.40
  • Zacks

    How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

    Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

  • Insider Monkey

    12 Most Shorted Stocks in 2024

    In this article, we will take a detailed look at the 12 Most Shorted Stocks in 2024. For a quick overview of such stocks, read our article 5 Most Shorted Stocks in 2024. Short-sellers may be annoying for corporations (and Redditors?), but investors usually find themselves thanking these companies for doing the often back-breaking and excruciating research that […]

  • GlobeNewswire

    Shah Capital nominates two highly qualified independent director candidates for Novavax

    Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price Shah Capital which owns 6.7% of Novavax, in a letter to the board says that the low share price reflects the board and management’s failure to capitalize on Novavax’s many significant competitive advantages and TAM opportunities The letter highlights that the underperformance is self-inflicted and is the result of reactive leadership and outd